Neutralizing antibody response against SARS-CoV-2 variants in health care workers pre- and post-vaccination
Numerous vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed, including two novel mRNA vaccines, Moderna mRNA-1273 and
Read more








